Pure Bioscience Inc – Strategy, SWOT and Corporate Finance Report

Pure Bioscience Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Pure Bioscience Inc (Pure) is involved in the development and commercialization of proprietary antimicrobial products. The company markets and develops proprietary antimicrobial products principally in the food safety field providing solutions to the health and environmental challenges of pathogen and hygienic control. Pure’s technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC), a broad-spectrum, non-toxic antimicrobial agents. It also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. Pure is headquartered in El Cajon, California, the US.

Scope

Detailed information on Pure Bioscience Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Pure Bioscience Inc in the form of a SWOT analysis

An in-depth view of the business model of Pure Bioscience Inc including a breakdown and examination of key business segments

News about Pure Bioscience Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Pure Bioscience Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Pure Bioscience Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Pure Bioscience Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

The Clorox Company

Steris Corp

Realm Therapeutics Inc

PRIMUS Sterilizer Company LLC

NovaSterilis Inc

Comfort Safety Products Inc

CareFusion Corp

Cantel Medical Corp

BioMedical Technology Solutions Holdings Inc

Advantec MFS Inc

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 - About the Company 5

Pure Bioscience Inc - Key Facts 5

Pure Bioscience Inc - Key Employees 6

Pure Bioscience Inc - Key Employee Biographies 7

Pure Bioscience Inc - Major Products and Services 8

Pure Bioscience Inc - History 9

Pure Bioscience Inc - Company Statement 12

Pure Bioscience Inc - Locations And Subsidiaries 13

Head Office 13

Section 2 Company Analysis 14

Company Overview 14

Pure Bioscience Inc - Business Description 15

Pure Bioscience Inc - SWOT Analysis 16

SWOT Analysis - Overview 16

Pure Bioscience Inc - Strengths 16

Pure Bioscience Inc - Weaknesses 17

Pure Bioscience Inc - Opportunities 18

Pure Bioscience Inc - Threats 19

Pure Bioscience Inc - Key Competitors 20

Section 3 Company Financial Ratios 21

Financial Ratios - Capital Market Ratios 21

Financial Ratios - Annual Ratios 22

Performance Chart 24

Financial Performance 24

Financial Ratios - Interim Ratios 25

Financial Ratios - Ratio Charts 26

Pure Bioscience Inc, Recent Deals Summary 27

Section 4 Company’s Recent Developments 28

Oct 25, 2018: PURE Bioscience reports fiscal 2018 year-end financial results 28

Jul 02, 2018: PURE Bioscience Raises $500,000 in Unsecured Promissory Note - Appoints Ivan Chen to Board of Directors 29

Jun 13, 2018: PURE Bioscience Reports Fiscal 2018 Third Quarter and Nine-Month Financial Results 30

Dec 14, 2017: PURE Bioscience Reports Fiscal 2018 Q1 Financial Results 31

Nov 02, 2017: PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety Consultant 32

Jun 08, 2017: PURE Bioscience reports 2017 fiscal Q3 and nine-month financial results 33

Apr 27, 2017: PURE Bioscience Receives USDA Permission Letter and FDA FCN Acknowledgement Letter 35

Mar 02, 2017: PURE Bioscience Reports Improved 2017 Fiscal Second Quarter and Six-Month Financial Results 36

Section 5 Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Tables

List of Tables

Pure Bioscience Inc, Key Facts 5

Pure Bioscience Inc, Key Employees 6

Pure Bioscience Inc, Key Employee Biographies 7

Pure Bioscience Inc, Major Products and Services 8

Pure Bioscience Inc, History 9

Pure Bioscience Inc, Key Competitors 20

Pure Bioscience Inc, Ratios based on current share price 21

Pure Bioscience Inc, Annual Ratios 22

Pure Bioscience Inc, Annual Ratios (Cont…1) 23

Pure Bioscience Inc, Interim Ratios 25

Pure Bioscience Inc, Recent Deals Summary 27

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

List of Figures

List of Figures

Pure Bioscience Inc, Performance Chart (2014 – 2018) 24

Pure Bioscience Inc, Ratio Charts 26

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports